Eden Research (LON:EDEN) Stock Price Down 0.2% – What’s Next?

Shares of Eden Research plc (LON:EDEN) fell 0.2% on Friday . The company traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The firm has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The stock has a fifty day simple moving average of GBX 3.87 and a two-hundred day simple moving average of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insider Transactions at Eden Research

In other Eden Research news, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). 14.02% of the stock is owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.